CYRNQ — Cyren Income Statement
0.000.00%
Last trade - 00:00
TechnologyHighly SpeculativeMicro Cap
- $0.00m
- -$4.80m
- $31.19m
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 30.8 | 35.9 | 38.4 | 36.4 | 31.2 |
Cost of Revenue | |||||
Gross Profit | 18.9 | 21.4 | 22.8 | 21.6 | 15.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 44.6 | 55.2 | 56.1 | 52.1 | 53 |
Operating Profit | -13.8 | -19.3 | -17.7 | -15.7 | -21.8 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -15.7 | -19.6 | -18.1 | -17.4 | -23.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -15.6 | -19.4 | -18 | -17.3 | -23 |
Net Income Before Extraordinary Items | |||||
Net Income | -15.6 | -19.4 | -18 | -17.3 | -23 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -15.6 | -19.4 | -18 | -17.3 | -23 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -7.65 | -7.24 | -6.59 | -5.72 | -5.9 |